228

Ўзбекистонлик витилиго билан касалланган беморлар тери ранги нисбаттан тўқроқ рангга эгалиги сабабли,тўқроқ рангли териларда депигментация ўчоқлари аниқ ажралиб туради ва бу касаллик билан боғлиқ бўлган муҳим омил саналади. 50та беморда интервью орқали изланиш ўтказилиб, касаллик беморлар ижтимоий хаёти, психосоциал ҳолати ва соғлом турмуштарзига қай даражада таъсир қилиши ўрганилди.

  • Jurnal nomi
  • Nashr soni
  • Ko'rishlar soni 228
  • Internet havola
  • DOIdoi.org/10.47100/conference_pedagogy/S2_8
  • UzSCI tizimida yaratilgan sana 14-08-2020
  • O'qishlar soni 122
  • Nashr sanasi
  • Asosiy tilO'zbek
  • Sahifalar48-58
Ўзбек

Ўзбекистонлик витилиго билан касалланган беморлар тери ранги нисбаттан тўқроқ рангга эгалиги сабабли,тўқроқ рангли териларда депигментация ўчоқлари аниқ ажралиб туради ва бу касаллик билан боғлиқ бўлган муҳим омил саналади. 50та беморда интервью орқали изланиш ўтказилиб, касаллик беморлар ижтимоий хаёти, психосоциал ҳолати ва соғлом турмуштарзига қай даражада таъсир қилиши ўрганилди.

Русский

Поскольку пациенты с витилиго в Узбекистане имеют относительно темный цвет кожи, очаги депигментации более выражены на ней, и это важный фактор, связанный с заболеванием. Опрос 50ти пациентов был проведен для изучения того, насколько заболевание влияет на социальную жизнь пациентов, психосоциальный статус и здоровый образ жизни

English

Since patients with vitiligo in Uzbekistan have a relatively dark skin color, foci of depigmentation are more pronounced on darker skin, and this is an important factor associated with the disease. A survey of 50 patients was conducted to study how the disease affects the patients' social life, psychosocial status and healthy lifestyle.

№ Havola nomi
1 Arifov C.C. Teri va tanosil kasalliklari. Toshkent 2010 152-bet.
2 Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: A comprehensive overview Part 1. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work up. J Am AcadDermatol. 2011;65:473–491. [PubMed] [Google Scholar]
3 Kent G, al-Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol 1996;21:330-3.[PUBMED]
4 Belhadjali H, Amri M, Mecheri A, Doarika A, Khorchani H, Youssef M, et al. Vitiligo and quality of life: A case-control study. Ann DermatolVenereol 2007;134:233-6. [PUBMED]
5 Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on selfreported health-related quality of life. Br J Dermatol 2005;152:1165-72.
6 Sharma N, Koranne RV, Singh RK. Psychiatric morbidity in psoriasis and vitiligo: A comparative study. J Dermatol 2001;28:419-23.
7 Firooz A, Bouzari N, Fallah N, Ghazisaidi B, Firoozabadi MR, Dowlati Y. What patients with vitiligo believe about their condition.Int J Dermatol 2004;43:811-4.
8 Porter J, Beuf AH, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders: A study of patients with vitiligo.GenHosp Psychiatry 1979;1:73 7.
9 Porter JR, Beuf AH, Lerner A, Nordlund J. Psychosocial effect of vitiligo: A comparison of vitiligo patients with "normal" control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am AcadDermatol 1986;15:2204.
10 Borimnejad L, ParsaYekta Z, Nikbakht-Nasrabadi A, Firooz A. Quality of life with vitiligo: Comparison of male and female muslim patients in Iran. Gend Med 2006;3:124-30
11 Hill-Beuf A, Porter JD. Children coping with impaired appearance: Social and psychologic influences. Gen Hosp Psychiatry 1984;6:294-301.
12 Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psychiatric morbidity in vitiligo: Prevalence and correlates in India. J EurAcadDermatolVenereol 2002;16:573-8. [PUBMED]
13 Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psychiatric morbidity in vitiligo and psoriasis: A comparative study from India. J Dermatol 2001;28:424-32. [PUBMED]
14 Giacomini MK, Cook DJ. Users' guides to the medical literature: XXIII. Qualitative research in health care A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 2000;284:357-62
15 Sofaer S. Qualitative methods: What are they and why use them? Health Serv Res 1999;34:1101-18. [PUBMED]
16 Porter J, Beuf AH, Lerner A, Nordlund J. Response to cosmetic disfigurement: Patients with vitiligo. Cutis 1987;39:493-4. [PUBMED]
17 Porter J. The psychological effects of vitiligo: Response to impaired appearance. In: Hann SK, Nordlund JJ, editors. Vitiligo a Monograph on the Basic and Clinical Science.Oxford: BlackwellScienceLtd.; 2000. p. 97-100
18 Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: A preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 1999;72:385-96. [PUBMED]
Kutilmoqda